Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,732,287 papers from all fields of science
Search
Sign In
Create Free Account
carboplatin/etoposide/ifosfamide
Known as:
ICE regimen
, CBDCA/IFF/VP-16
, Ifosfamide-Carboplatin-Etoposide Regimen
Expand
An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin and Hodgkin lymphomas that have come back and do not respond to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Carboplatin
Etoposide
Ifosfamide
Paraplatin
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Necrotizing Fasciitis is a Rare Complication after Bone Marrow Transplantation: A Case Report
M. Payandeh
,
M. Zamanian
,
Cyrus Rezaei
,
Sakineh Ghorbani
,
M. Aeinfar
,
M. Sadeghi
2017
Corpus ID: 79804011
Necrotizing fasciitis is an uncommon disease and a soft tissue infection that spreads along fascial planes with associated…
Expand
2016
2016
Efficacy of salvage chemotherapy with ICE regimen in 52 patients with recurrent and refractory diffuse large B-cell lymphoma and its prognostic factors
Meifang Li
,
Yu Yang
,
Dao-guang Chen
,
Si-ping Zou
2016
Corpus ID: 78434707
Objective: To investigate the efficacy and safety of salvage chemotherapy with ICE regimen (ifosfamide, etoposide and carboplatin…
Expand
2012
2012
Clinical Comparative Study of the Effect of MINE and ICE Regimen on Relapsed and Refractory Lymphoma
Li Liang-qun
2012
Corpus ID: 57951815
Objective To compare the effect and safety of MINE and ICE Regimen in the treatment of relapsed and refractory lymphoma.Methods…
Expand
2001
2001
Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
F. Leoni
,
S. Ciolli
,
C. Nozzoli
,
V. Santini
,
R. Fanci
,
P. Rossi Ferrini
Haematologica
2001
Corpus ID: 5875637
Unfavorable biological characteristics and host-related factors adversely affect the prognosis of acute myeloid leukemia (AML) in…
Expand
2001
2001
Three Conventional-Drug Combination (Ifosfamide, Carboplatin, Etoposide - ICE Regimen) in Advanced Non-Small Cell Lung Cancer (NSCLC)
A. Cuomo
,
F. Cuna
,
P. Baiardi
,
R. Torazzo
,
P. Preti
,
G. R. Cuna
Journal of chemotherapy
2001
Corpus ID: 30957981
Abstract Fifty consecutive patients with stage IIIB-IV non-small cell lung cancer (NSCLC) received the ICE regimen at…
Expand
2000
2000
Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
F. Silvestri
,
A. Sperotto
,
A. Ermacora
,
R. Fanin
,
D. Damiani
,
M. Baccarani
Haematologica
2000
Corpus ID: 46451899
tologic toxicities were milder than with the ICE regimen. Moreover, days of neutropenic fever, hospitalization and consumption of…
Expand
1998
1998
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC).
P. Preti
,
G. Poggi
,
A. Cuomo
,
F. S. Robustelli della Cuna
,
A. Zambelli
,
L. Pavesi
Journal of chemotherapy
1998
Corpus ID: 51830
We have evaluated the combination of ifosfamide, carboplatin and etoposide (ICE regimen) along with mesna in 26 previously…
Expand